Metagenomic Sequencing

Pair Metagenomic Sequencing with Metabolomics for a Complete View of Microbiome Function

Integrating metagenomics sequencing with metabolomics links microbial composition to functional outputs to drive a deeper understanding of microbiome impact on host health.

  • Flexible Options - Amplicon and Shotgun Sequencing
  • Powerful Bioinformatics Tools for Data Integration
  • Metabolites as a Phenotypic Output of the Microbial Community Composition

Speak to a Microbiome Expert Today

Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research.

mayo clinic
mayo clinic
mayo clinic
mayo clinic
mayo clinic
mayo clinic
metabolomics academic 1
$

Multiomic Microbiome Analysis

Reveal the Impact of the Microbiome on Host Health

The microbiome is now widely recognized as a key driver of human health, significantly impacting immunity, metabolism, and disease susceptibility. As a result, microbiome biology has rightfully become a key focus across diverse fields of biomedical research. A critical tool in this field is metagenomic sequencing, which has long been used to assess the composition of microbial communities and, more recently, to characterize the microbiome’s gene-coding potential through deep shotgun sequencing.

While metagenomics identifies microbial species and their genetic potential, it does not capture their functional contributions—what they are actively metabolizing—that affects the host. Metabolomics, the measure of the small molecule repertoire present in a sample, addresses this gap by providing a phenotypic readout of microbiome activity. By integrating metagenomics with metabolomics, researchers can gain a deeper understanding of microbial composition, function and its impact on host health.

Metagenomic Sequencing Options

Selecting the right metagenomic sequencing option is essential for achieving study goals while balancing cost and the depth of insights needed to answer your research questions. Metabolon offers multiple metagenomics sequencing options, including 16S Amplicon Sequencing and Shotgun Sequencing at various depths optimized for fecal samples. Learn more about our sequencing options here. By deeply understanding a study’s objectives and budget, Metabolon can help select the metagenomics sequencing option that delivers the best value and insights to advance your research goals.

K
L
Amplicon (16S) Sequencing

Amplicon sequencing enables microbial community composition evaluation by sequencing characteristic regions of the 16S rRNA gene to classify archaea and bacteria.

K
L
Shotgun Sequencing, Shallow (3 Million Reads)

For preliminary research or studies focused on broad microbial trends, the Shallow option can often be sufficient to explore community composition and differences across groups. This option provides a cost-effective means to obtain adequate data to identify dominant species and patterns.

K
L
Shotgun Sequencing, Balance (15 Million Reads)

The Balance option offers a good balance between cost and depth of insights. This option provides an overview of both dominant and some less abundant species and begins to represent the gene function potential encoded by the microbial community.

K
L
Shotgun Sequencing, Deep (20 Million Reads)

For detecting rare microbial species or performing highly detailed gene function analyses, the Deep and Ultra Deep options provide the highest levels of detail. The Deep option provides in-depth coverage to capture more species diversity, rare microbes and rare gene functions.

K
L
Shotgun Sequencing, Ultra Deep (80 Million Reads)

This option provides ultra-high resolution, capable of capturing rare species, rare genes, and subtle functional differences driven by small variations in gene sequence. This option can most benefit researchers who have their own bioinformatics team to most fully leverage functional information available in this depth of data.

Our Microbiome Research Solution

Metabolon’s Microbiome Research Solution is a complete full-service offering for high-quality metabolomics and metagenomics data generation, user-friendly multiomic data analysis, and biological interpretation that can accelerate your microbiome research.

Global Discovery Panel

Global Discovery Panel

Metabolon’s metabolomics technology can detect and identify up to 5,400 metabolites in a single biological sample.

Global Discovery Panel

Microbiome Panel

A highly-curated metabolomics panel that screens for more than 800 key small molecules to accelerate microbiome discovery.

Global Discovery Panel

Microbiome Analysis Tool

Unify metagenomic, metabolomic, and phenotypic data within a codeless, accessible platform that simplifies complex analyses.

Featured Resources

Learn more about how metabolomics and metagenomics can help you better understand the microbiome’s impact on health.

$

eBrochure: Global Discovery Panel

$

Live Webinar: Unravelling Microbiome Insights

$

Whitepaper: Guidance for Metagenomics Sequencing

GET STARTED

Talk with an expert

Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research. Find our contact details are here.

Find us on:

Talk with a Metabolomics expert

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.